ALL patients who received Aucatzyl immunotherapy, made from their own T cells, experienced complete remission within three ...

Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

to assess the benefits and harms of currently recommended regimens as the first-line therapy in high-risk people with chronic lymphocytic leukemia, using network meta-analysis Secondary objectives: to ...

Dr. Halwani’s practice at Huntsman Cancer Institute focuses on lymphoid malignancies, specifically Lymphoma and Chronic Lymphocytic Leukemia (CLL). Dr. Halwani was also responsible for leading an ...

Ongoing international oncology collaboration works to empower health care workers and save lives across diverse resource environments. NCCN Harmonized Guidelines for ...

This is the latest event from a longstanding collaboration between the African Cancer Coalition (ACC), American Cancer Society (ACS), and National Comprehensive Cancer Network® (NCCN®), and the ...

International oncology experts are gathering in Accra, Ghana for a series of meetings beginning today, to update cancer ...